Ligand profile
ZINC196899382
Virtual-screening candidate from ZINC.
Bound to: KP13_01017 — Lysine-arginine-ornithine-binding periplasmic protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC196899382- UniProt (similar protein)
Q83E49- Tanimoto
- 0.588
- Target protein
- KP13_01017
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 92.4
- −1 ≤ LogP ≤ 5 -0.14
- MW ≤ 500 Da 228.2
- LogP ≤ 5 -0.14
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 92.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
N[C@@H](CCCNC(=O)C(F)(F)F)C(=O)ON[C@@H](CCCNC(=O)C(F)(F)F)C(=O)O
InChI=1S/C7H11F3N2O3/c8-7(9,10)6(15)12-3-1-2-4(11)5(13)14/h4H,1-3,11H2,(H,12,15)(H,13,14)/t4-/m0/s1InChI=1S/C7H11F3N2O3/c8-7(9,10)6(15)12-3-1-2-4(11)5(13)14/h4H,1-3,11H2,(H,12,15)(H,13,14)/t4-/m0/s1
BEEAVYYIFAMIIT-BYPYZUCNSA-NBEEAVYYIFAMIIT-BYPYZUCNSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- ARG
- Homolog
- Q83E49
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC196899382 →
- ZINC ZINC20 ZINC196899382 →
- UniProt UniProt Q83E49 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC196899382”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01017.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).